News

Head/Neck Cancer Treatments Less Effective in HIV Patients

Publish date: January 26, 2012

 

FROM A HEAD AND NECK CANCER SYMPOSIUM BY THE AMERICAN SOCIETY FOR RADIATION ONCOLOGY

Dr. Mourad and his nine coauthors declared that they had no financial disclosures.

Pages

Recommended Reading

Paraneoplastic Autoimmune Multiorgan Syndrome Proves Rapidly Fatal
MDedge Dermatology
FDA Approves Vemurafenib for Advanced Melanoma
MDedge Dermatology
Oncovirus Expert: Cattle May Transmit Human Cancers
MDedge Dermatology
Vismodegib Shrinks Advanced Basal Cell Carcinoma
MDedge Dermatology
Series of Articles on Melanoma Aimed at Informing Policy
MDedge Dermatology
Atopy May Protect Against Skin Cancer
MDedge Dermatology
FDA Steps Up Cancer Surveillance of TNF Blockers
MDedge Dermatology
JAK Inhibitor Ruxolitinib Wins First FDA Approval in Myelofibrosis
MDedge Dermatology
Breast Cancer Vaccine Begins Phase III Trial
MDedge Dermatology
Oral HPV Infection More Prevalent in Men Than Women
MDedge Dermatology